Champions Oncology, Inc.: Form 10-Q for the period ended Jul 31, 2016
Filed with the SEC on Sep 14, 2016 and accepted by EDGAR at Sep 14, 2016, 15:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2016-05-01 to 2016-07-31 | $1.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2016-05-01 to 2016-07-31 | −$2.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-05-01 to 2016-07-31 | $14.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-05-01 to 2016-07-31 | −$2.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-05-01 to 2016-07-31 | −$0.26 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months2016-05-01 to 2016-07-31 | −$2.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2016-05-01 to 2016-07-31 | $17.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-07-31 | $4.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-07-31 | $6.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-07-31 | $7.8m | us-gaap:Assets |
| Current liabilities | At period end2016-07-31 | $4.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-07-31 | $4.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-07-31 | $3.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-16-019568. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.